CNXU

Conexeu Sciences Inc. CNXU

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Net income

$-7.73M

Quarter to Jul 31

Free cash flow

$-6.80M

Quarter to Jul 31

Top Institutional Holders

as of Q2 2026
$282.5K total
UBS Group AG
$133.9K--
MORGAN STANLEY
$64.1K--
CITIGROUP INC
$57.0K--
HOLLENCREST SECURITIES LLC
$10.9K--
ROYAL BANK OF CANADA
$10.0K--
Integrated Wealth Concepts LLC
$4.4K--
JONES FINANCIAL COMPANIES LLLP
$1.1K--
OSAIC HOLDINGS, INC.
$1.1K--
See all 8 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q3 2026
EDGAR

EPS (Diluted)

Q3 2026
EDGAR

Free Cash Flow

Q3 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/CNXU

Earnings Per Share

13fpro.ai/company/CNXU

Loading ratio trend…

CNXU insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Conexeu Sciences Inc. (CNXU): stock profile, AI score and financials

Conexeu Sciences Inc. (CNXU) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. CNXU is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (Q3 2026), Conexeu Sciences Inc. reports net income of $-7.7M, free cash flow of $-6.8M. Top institutional holders of CNXU by reported 13-F value include UBS Group AG, MORGAN STANLEY, CITIGROUP, based on the most recent SEC filings. CNXU trades on the Nasdaq exchange and files with the SEC under CIK 2066836. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CNXU daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Conexeu Sciences Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 2066836 →